A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial
- Ronald D. Alvarez
- , Mack N. Barnes
- , Jesus Gomez-Navarro
- , Minghui Wang
- , Theresa V. Strong
- , Waleed Arafat
- , Ramin B. Arani
- , Martin R. Johnson
- , Bruce L. Roberts
- , Gene P. Siegal
- , David T. Curiel
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Bursky Center for Human Immunology and Immunotherapy
- Department of Radiation Oncology
- Center of Regenerative Medicine
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Molecular Genetics and Genomics
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
159
Link opens in a new tab
Scopus
citations